BioNanoNet is a bionanotechnology network in Austria that carries out innovative interdisciplinary research in the field of drug development. Within this network new agents, action and application strategies are being developed by using techniques of nanotechnology. Research efforts are aimed at finding new agents and new treatment strategies for chronic degenerative and infectious diseases.
The goal of the MultiPlat project is to develop biomimetic proton conductive membranes with nanometer thickness (nanomembranes) through convergence of the number of fields. The primary application of this multipurpose nanotechnological platform is the next generation of fuel cells where it will replace the prevailing evolutionary modifications of the state of the art solutions.
An ITA (Institute of Technology Assessment) Project - Integrative Analysis of the State of Knowledge Regarding Health and Environmental Risks of Nanotechnology. The heart of the research project is to continually survey, analyse and summarise the state of knowledge regarding potential health and environmental risks of nanotechnology.
Within the NILaustria project cluster the consortium will use Nanoimprint Lithography (NIL) to provide a versatile and cost efficient solution to achieve ultra high quality, large area nanostructures. The consortium brings together all Austrian research institutions using NIL and the two NIL-related companies in Austria, i.e. NIL equipment manufacturer EVG and IMS developing a novel method for NIL template fabrication.